MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Wu, Jiangbin ^a   Lv, Qing ^a   He, Jie ^a   Zhang, Haoxiang ^a   Mei, Xueshuang ^b   Cui, Kai ^a   Huang, Nunu ^a   Xie, Weidong ^a   Xu, Naihan ^a   Zhang, Yaou ^a  

^a TSINGHUA UNIVERSITY   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

CDK; Cell cycle; Cyclin; E2F; G1 S transition; MiR 188; Rb

Indexed keywords

CYCLIN A2; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLINE; CYCLINE E1; MICRORNA; MICRORNA 188; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; MIRN188 MICRORNA, HUMAN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER INHIBITION; CCNA2 GENE; CCND1 GENE; CCND3 GENE; CCNE1 GENE; CDK2 GENE; CDK4 GENE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; INTERPHASE; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLINS; E2F TRANSCRIPTION FACTORS; HUMANS; INTERPHASE; MICE, NUDE; MICRORNAS; NEOPLASMS; RETINOBLASTOMA PROTEIN;

EID: 84964695681     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0066-6     Document Type: Article

References (63)

1. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Shyh-Chang N, Daley GQ: Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 2013, 12:395-406.
3. Zhou J, Wang W, Gao Z, Peng X, Chen X, Chen W, Xu W, Xu H, Lin MC, Jiang S: MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PLoS One 2013, 8:e83055.
4. Yang J, Zhao H, Xin Y, Fan L: MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. J Cell Biochem 2014, 115:987-995.
5. Huang HN, Chen SY, Hwang SM, Yu CC, Su MW, Mai W, Wang HW, Cheng WC, Schuyler SC, Ma N, Lu FL, Lu J: miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation. Stem Cell Res 2013, 12:338-353.
6. Yi C, Xie WD, Li F, Lv Q, He J, Wu J, Gu D, Xu N, Zhang Y: MiR-143 enhances adipogenic differentiation of 3 T3-L1 cells through targeting the coding region of mouse pleiotrophin. FEBS Lett 2011, 585:3303-3309.
7. Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, Chen WT: Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 2013, 32:61-69.
8. Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, Qi X, Gautron L, Elmquist JK, Bassel-Duby R, Olson EN: A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 2012, 149:671-683.
9. Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, Urbach A, Thornton JE, Triboulet R, Gregory RI, Altshuler D, Daley GQ, DIAGRAM Consortium; MAGIC Investigators: The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147:81-94.
10. Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ: MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 2009, 100:1002-1011.
11. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW: Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A 2008, 105:13021-13026.
12. Bartel DP, Chen CZ: Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
13. He J, Wu J, Xu N, Xie W, Li M, Li J, Jiang Y, Yang BB, Zhang Y: MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes. Nucleic Acids Res 2013, 41:498-508.
14. Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, Tavazoie SF: Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 2012, 151:1068-1082.
15. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M: Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012, 492:376-381.
16. Frankel LB, Lund AH: MicroRNA regulation of autophagy. Carcinogenesis 2012, 33:2018-2025.
17. Dumortier O, Hinault C, Van Obberghen E: MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab 2013, 18:312-324.
18. Duronio RJ, Xiong Y: Signaling pathways that control cell proliferation. Cold Spring Harbor Perspect Biol 2013, 5:a008904.
19. Malumbres M, Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009, 9:153-166.
20. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J 1992, 11:961-971.
21. Murphree AL, Benedict WF: Retinoblastoma: clues to human oncogenesis. Science 1984, 223:1028-1033.
22. Giacinti C, Giordano A: RB and cell cycle progression. Oncogene 2006, 25:5220-5227.
23. Neganova I, Lako M: G1 to S phase cell cycle transition in somatic and embryonic stem cells. J Anat 2008, 213:30-44.
24. Frolov MV, Dyson NJ: Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J Cell Sci 2004, 117:2173-2181.
25. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De MR: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008, 14:1271-1277.
26. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X: miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008, 36:5391-5404.
27. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z, Zheng X: Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008, 582:1564-1568.
28. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J: Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008, 68:2094-2105.
29. Pierson J, Hostager B, Fan R, Vibhakar R: Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neuro-Oncol 2008, 90:1-7.
30. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M: Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007, 67:1424-1429.
31. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008, 6:14.
32. Alteri A, De Vito F, Messina G, Pompili M, Calconi A, Visca P, Mottolese M, Presutti C, Grossi M: Cyclin D1 is a major target of miR-206 in cell differentiation and transformation. Cell Cycle 2013, 12:3781-3790.
33. Chen D, Farwell MA, Zhang B: MicroRNA as a new player in the cell cycle. J Cell Physiol 2010, 225:296-301.
34. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T: New microRNAs from mouse and human. RNA 2003, 9:175-179.
35. Lee K, KimJH, Kwon OB, An K, Ryu J, Cho K, Suh YH, KimHS: An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2. J Neurosci Off J Soc Neurosci 2012, 32:5678-5687.
36. Xu Y, Zhou B, Wu D, Yin Z, Luo D: Baicalin modulates microRNA expression in UVB irradiated mouse skin. J Biomed Res 2012, 26:125-134.
37. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y: MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006, 1:e116.
38. Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
39. Huang DW, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
40. Murray AW: Recycling the cell cycle: cyclins revisited. Cell 2004, 116:221-234.
41. Munro S, Carr SM, La Thangue NB: Diversity within the pRb pathway: is there a code of conduct? Oncogene 2012, 31:4343-4352.
42. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW: Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716.
43. Bukholm IR, Bukholm G, Nesland JM: Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer 2001, 93:283-287.
44. Taran K, Owecka A, Kobos J: Prognostic importance of cyclin E1 expression in neuroblastic tumors in children. Pol J Pathol 2013, 64:149-152.
45. Baker SJ, Reddy EP: CDK4: a key player in the cell cycle, development, and cancer. Genes Cancer 2012, 3:658-669.
46. Choi YJ, Li X, Hydbring P, Sanda T, Stefano J, Christie AL, Signoretti S, Look AT, Kung AL, von Boehmer H, Sicinski P: The requirement for cyclin D function in tumor maintenance. Cancer Cell 2012, 22:438-451.
47. Deshpande A, Sicinski P, Hinds PW: Cyclins and cdks in development and cancer: a perspective. Oncogene 2005, 24:2909-2915.
48. Xu XL, Chen SZ, Chen W, Zheng WH, Xia XH, Yang HJ, Li B, Mao WM: The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis. Breast Cancer Res Treat 2013, 139:329-339.
49. Peurala E, Koivunen P, Haapasaari KM, Bloigu R, Jukkola-Vuorinen A: The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. Breast Cancer Res 2013, 15:R5.
50. Li ZM, Spagnuolo L, Mensah AA, Rinaldi A, Bhagat G, Zucca E, Doglioni C, Ferreri AJ, Ponzoni M, Bertoni F: Gains of CCND3 gene in ocular adnexal MALT lymphomas: an integrated analysis. Br J Haematol 2013, 160:719-722.
51. Sawai CM, Freund J, Oh P, Ndiaye-Lobry D, Bretz JC, Strikoudis A, Genesca L, Trimarchi T, Kelliher MA, Clark M, Soulier J, Chen-Kiang S, Aifantis I: Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell 2012, 22:452-465.
52. An HX, Beckmann MW, Reifenberger G, Bender HG, Niederacher D: Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am J Pathol 1999, 154:113-118.
53. Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ, Cavenee WK: Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res 1997, 57:1250-1254.
54. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H, Ingvar C: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000, 92:1260-1266.
55. Bueno MJ, Malumbres M: MicroRNAs and the cell cycle. Biochim Biophys Acta 1812, 2011:592-601.
56. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K: MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009, 113:396-402.
57. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X: Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene 2010, 29:2302-2308.
58. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M: MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008, 27:5651-5661.
59. Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM, Stein GS: MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 2008, 68:2773-2780.
60. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
61. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
62. Ye W, Lv Q, Wong CK, Hu S, Fu C, Hua Z, Cai G, Li G, Yang BB, Zhang Y: The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One 2008, 3:e1719.
63. Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E: Heterodimerization of the transcription factors E2f-1 and Dp-1 leads to cooperative transactivation. Gene Dev 1993, 7:1850-1861.